期刊
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
卷 65, 期 12, 页码 1295-1305出版社
WILEY
DOI: 10.1111/j.1742-1241.2011.02810.x
关键词
-
资金
- National Basic Research Program of China (973 Program) [2011CB711000]
- government of SiChuan province of china [2010FZ0061]
- health department in the government of SiChuan province
- government of MianYang City [09s001]
- third hospital of mianyang
The association of antihypertensive medication use with cognitive decline (including mild cognitive impairment) or dementia (including Alzheimers disease (AD), vascular dementia (VD) and any dementia) has still been an area of controversy. This study examined the association of antihypertensive medication use with cognitive decline or dementia using a quantitative meta-analysis of longitudinal studies. EMBASE and MEDLINE were searched for articles published up to Feb 2011. All studies that examined the relationship between antihypertensive medication use and the incidence of dementia or cognitive decline were included. Pooled relative risk (RR) was calculated using fixed and random-effects models. Fourteen studies met our inclusion criteria for this meta-analysis. All subjects were without dementia or cognitive impairment at baseline. There were subjects with (32,658) and without (36,905) antihypertensive medication use. The quantitative meta-analysis showed that there was no significant difference in incidence of AD (RR: 0.90, 95% confidence interval (CI): 0.791.03), cognitive decline (RR: 0.97; 95% CI: 0.921.03) and cognitive impairment (RR: 0.97; 95% CI: 0.921.03). The quantitative meta-analysis showed that the subjects with antihypertensive medication use were lower incidence of VD (RR: 0.67, 95% CI: 0.520.87) and any dementia (RR: 0.87; 95% CI: 0.770.96) than those without. The quantitative meta-analysis showed that antihypertensive medication use could decrease risk of the development of VD and any dementia, but could not decrease that of AD, cognitive decline and cognitive impairment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据